Nu-Med Plus

Reinventing the Healing Power of Nitric Oxide Delivery. Nu-Med Plus engineers patented technology to safely deliver precision doses of nitric oxide. A line of innovative systems are being developed to serve new patient populations. Delivered correctly, nitric oxide holds the potential to dilate constricted blood vessels in heart patients and heal respiratory complications in newborns. Nu-Med scientists employ patented and patent-pending technology to also explore the potential of nitric oxide to treat wound care and those suffering from malaria, COPD, tuberculosis and ARDS. Explore our products, pipeline, and join us in bringing this life-saving technology to new markets.

• Employees 2
• Founded 2011
• Annual Revenue $0
• Total Funding $772905